6533b85afe1ef96bd12b92f2
RESEARCH PRODUCT
Favorable evolution post hematologous stem cell transplant after primary central nervous system lymphoma in a multiple sclerosis under natalizumab
A. FromontR.o. CasasnovasC. BillyL. MartinThibault Moreausubject
[SDV.CAN] Life Sciences [q-bio]/CancerClinical NeurologyNeurosciences[SDV.CAN]Life Sciences [q-bio]/Cancer[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC][SDV.NEU] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]ComputingMilieux_MISCELLANEOUSdescription
International audience
year | journal | country | edition | language |
---|---|---|---|---|
2017-10-25 |